Glucagon-like peptide-1 receptor agonists (GLP-1RAs), including semaglutide and tirzepatide, have rapidly reshaped the management of type 2 diabetes and obesity. Their ability to lower blood glucose, reduce body weight, and modulate appetite has been hailed as a therapeutic breakthrough. But as these agents move from niche to mainstream, clinicians across disciplines are discovering their broader […]
Recent Posts
- GLP-1 Receptor Agonists and Oral Health: Essential Insights for Dentists
- “Why Saliva pH Testing Should Be Mandatory in Dentistry: Prevent Diet-Induced Cavities”
- DIM: A Breakthrough Natural Compound for Preventing Tooth Decay
- Neuromuscular Dentistry & Myocentric Mandate: Boosting Systemic Health Beyond Occlusion
- Vasa Denticity ( Dentkart)Buys 51% of IDS Denmed, Creating India’s Largest Dental Supply Network
Archives